Dr. Gerhard Müller is a chemist by training. He has had senior management roles in the pharma and biotech industry leading the discovery of small-molecule drug candidates for numerous target classes. He is former Senior Vice President Medicinal Chemistry at Mercachem bv and currently serves as Chief Scientific Officer at Gotham Therapeutics.
Dr. Jeanette Wood held various senior research leadership positions in big Pharma and small Biotech and has a track record of drugs progressed to clinical trials and to the market. She has extensive experience in all aspects of drug discovery and is author of more than 100 peer-reviewed publications and numerous patents. Jeanette currently serves as independent strategic and scientific consultant for biotech and academic institutions.
Dr. Dirk Weber is an MD PhD with over 15 years of experience in the pharmaceutical industry where he held senior leadership positions managing early and late stage clinical and regulatory aspects of oncology drug development from first-in-man studies to gain market authorization and the launch of oncology products. He also co-founded the two biotech companies Aurealis Pharma AG and Cellestia Biotech AG and currently serves them as CMO/Board member and CMO respectively.